Dropout Rate Blinding Good Clinical Practice (GCP) Phase I Institutional Review Board (IRB) Regulatory Authority Open- Label Trial Phase II Trial Registry Eligibility Criteria Phase IV Protocol Informed Consent Efficacy Ethics Committee Data Management Placebo Intervention Adverse Event Data Lock Parallel Study Protocol Deviation Source Data Verification Pilot Study Double- Blind Study Trial Monitor Data Safety Monitoring Board (DSMB) Control Group Safety Profile Clinical Research Coordinator Patient Recruitment Follow- up Visit Standard Operating Procedure (SOP) Statistical Analysis Plan (SAP) Adaptive Design Crossover Study Endpoint Recruitment Target Audit Trail Clinical Study Report (CSR) Screening Visit Surrogate Endpoint Clinical Endpoint Principal Investigator Multicenter Trial Sponsor Investigator Meeting Case Report Form (CRF) Randomization Phase III Dropout Rate Blinding Good Clinical Practice (GCP) Phase I Institutional Review Board (IRB) Regulatory Authority Open- Label Trial Phase II Trial Registry Eligibility Criteria Phase IV Protocol Informed Consent Efficacy Ethics Committee Data Management Placebo Intervention Adverse Event Data Lock Parallel Study Protocol Deviation Source Data Verification Pilot Study Double- Blind Study Trial Monitor Data Safety Monitoring Board (DSMB) Control Group Safety Profile Clinical Research Coordinator Patient Recruitment Follow- up Visit Standard Operating Procedure (SOP) Statistical Analysis Plan (SAP) Adaptive Design Crossover Study Endpoint Recruitment Target Audit Trail Clinical Study Report (CSR) Screening Visit Surrogate Endpoint Clinical Endpoint Principal Investigator Multicenter Trial Sponsor Investigator Meeting Case Report Form (CRF) Randomization Phase III
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Dropout Rate
Blinding
Good Clinical Practice (GCP)
Phase I
Institutional Review Board (IRB)
Regulatory Authority
Open-Label Trial
Phase II
Trial Registry
Eligibility Criteria
Phase IV
Protocol
Informed Consent
Efficacy
Ethics Committee
Data Management
Placebo
Intervention
Adverse Event
Data Lock
Parallel Study
Protocol Deviation
Source Data Verification
Pilot Study
Double-Blind Study
Trial Monitor
Data Safety Monitoring Board (DSMB)
Control Group
Safety Profile
Clinical Research Coordinator
Patient Recruitment
Follow-up Visit
Standard Operating Procedure (SOP)
Statistical Analysis Plan (SAP)
Adaptive Design
Crossover Study
Endpoint
Recruitment Target
Audit Trail
Clinical Study Report (CSR)
Screening Visit
Surrogate Endpoint
Clinical Endpoint
Principal Investigator
Multicenter Trial
Sponsor
Investigator Meeting
Case Report Form (CRF)
Randomization
Phase III